It is all about securing the CAR-T cells for the trials at this stage. The next problem would be how to secure the cells should Azer-Cel become an approved treatment as multiples of the current production would be needed. If IMU is clever they will sell Azer-Cel and leave that problem to the buyer / partner who might have their own facility.
The cost reduction is significant while they ( hopefully ) still have access to their cells. But I guess LC will have that sorted.
A few times I wrote about some PH-decisions that made no sense at all at that time " I hope one day we can say - Ah, that's why! " Today is one of those days as it now makes sense that CHM has secured its own cells independent of IMU. A shared facility would have made sense for both in September '23 but both LC and CHM's JC told me that won't happen - now we know why. If all the other Hopper decisions will make sense in the LT then I owe him a big apology.
GLTA
It is all about securing the CAR-T cells for the trials at this...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
-0.003(3.53%) |
Mkt cap ! $600.2M | |||
| Open | High | Low | Value | Volume |
| 8.5¢ | 8.6¢ | 8.2¢ | $1.246M | 14.84M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 446526 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 535664 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.2¢ |
Change
-0.003 ( 2.38 %) |
||||
| Open | High | Low | Volume | ||
| 8.6¢ | 8.6¢ | 8.2¢ | 4518456 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| IMU (ASX) Chart |